Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase III Randomized Double-blind, 12 Week, Placebo Controlled Trial of Transdermal Selegiline in Borderline Personality Disorder (BPD) to Evaluate Efficacy and Safety
Brief Summary: Selegiline is superior to placebo in improving psychological and physical functioning in patients with Borderline Personality Disorder.